Xhevahire Begic - Sponsored Research Coordinating Center, Levine Cancer Institute

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 20 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

OA-57 Results of a Phase 1 Clinical Trial of Belantamab Mafadotin (belmaf) Combined with Carfilzomib, Lenalidomide, and Dexamethasone (krd) for Multiple Myeloma (MM) after One Prior Line of Therapy (LOT)

Shebli Atrash,James Symanowski,Sarah Norek, Monica Plott, Robin Cox, Cecilia Flynn,Kelly Bumgarner, Darynne Rhinehardt,Xhevahire Begic,Reed Friend,Barry Paul,Cindy Varga,Christopher Ferreri,Mauricio Pineda-Roman,Manisha Bhutani, Peter M. Voorhees

Clinical Lymphoma Myeloma and Leukemia (2024): S36

引用0浏览0引用

Multi-Center Prospective Phase Ii Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy (Sbrt) Followed by Concurrent Mediastinal Chemoradiation and Adjuvant Immunotherapy for Locallyadvanced Non-Small Cell Lung Cancer

John H. Heinzerling,Kathryn F. Mileham,Myra Robinson, Raghava R. Induru, Gregory Brouse,Christopher D. Corso,Roshan S. Prabhu,Daniel E. Haggstrom,Benjamin J. Moeller, William E. Bobo,Carolina E. Fasola, Vipul Thakkar, Sridhar E. Pal, Jenna Gregory,Sarah Norek,Xhevahire J. Begic, Aparna Kesarwala,Stuart H. Burri,Charles B. Simone, II

crossref（2024）

引用0浏览0引用

Results of a Phase 1 Clinical Trial of Belantamab Mafadotin (belmaf) Combined with Carfilzomib, Lenalidomide, and Dexamethasone (krd) for Multiple Myeloma (MM) after One Prior Line of Therapy (LOT)

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2024): S36-S36

引用0浏览0引用

Final Results of Phase 1 Clinical Trial of Belantamab Mafodotin Combined with Carfilzomib, Lenalidomide, and Dexamethasone for Multiple Myeloma after One to Three Prior Lines of Therapy

Shebli Atrash,James Symanowski,Sarah Norek, Monica Plott, Cecilia Flynn,Kelly Bumgarner, Darynne Rhinehardt,Xhevahire Begic, Robin Cox, Barry Paul,Cindy Varga,Reed Friend,Christopher Ferreri,Manisha Bhutani,Mauricio Pineda-Roman,Peter M. Voorhees

Bloodno. Supplement 1 (2024): 4751-4751

引用0浏览0引用

Primary Lung Tumour Stereotactic Body Radiotherapy Followed by Concurrent Mediastinal Chemoradiotherapy and Adjuvant Immunotherapy for Locally Advanced Non-Small-cell Lung Cancer: a Multicentre, Single-Arm, Phase 2 Trial

John H Heinzerling,Kathryn F Mileham,Myra M Robinson,James T Symanowski, Raghava R Induru, Gregory M Brouse,Christopher D Corso,Roshan S Prabhu,Daniel E Haggstrom,Benjamin J Moeller, William E Bobo,Carolina E Fasola, Vipul V Thakkar, Sridhar E Pal, Jenna M Gregory, Sarah L Norek,Xhevahire J Begic,Aparna H Kesarwala, Stuart H Burri,Charles B Simone

The Lancet Oncologyno. 1 (2024): 85-97

引用0浏览0WOS引用

MRD-driven Phase 2 Study of Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma

Manisha Bhutani,Myra Robinson,David Foureau,Shebli Atrash, Barry Paul, Fei Guo, Jason M Grayson, Anna Ivanina-Foureau,Mauricio Pineda-Roman,Cindy Varga,Reed Friend,Christopher J. Ferreri,Xhevahire Begic,Sarah Norek, Tiffany Drennan, Michelle B Anderson,James T. Symanowski,Peter M. Voorhees,Saad Z. Usmani

Blood Advances (2024)

引用0浏览0WOS引用

Supplementary Material from Phase II Study of Pembrolizumab in Combination with Doxorubicin in Metastatic and Unresectable Soft-Tissue Sarcoma

Michael B. Livingston,Megan H. Jagosky,Myra Robinson,William A. Ahrens,Jennifer H. Benbow,Carol Farhangfar,David M. Foureau,Deirdre M. Maxwell,Emily A. Baldrige,Xhevahire Begic,James T. Symanowski,Nury Steuerwald,Colin Anderson,Joshua C. Patt,Jeffrey S. Kneisl,Edward S. Kim

openalex（2023）

引用0浏览0引用

Primary Endpoint Analysis from a Response Adaptive Phase II Clinical Trial of Carfilzomib, Lenalidomide, Dexamethasone Plus Daratumumab (Krd-Dara) in Patients with Newly Diagnosed Multiple Myeloma (NDMM)

Manisha Bhutani,Myra Robinson,Barry Paul,Shebli Atrash,Cindy Varga,Xhevahire Begic,David M. Foureau,Mauricio Pineda-Roman,Brinda Koya,Sarah Norek, Sara A. Sutton, Michelle B. Anderson, Donna Acampora,James T. Symanowski,Peter M. Voorhees,Saad Usmani

Blood（2023）

引用4浏览0引用

Supplemental Table 2 from Phase II Study of Pembrolizumab in Combination with Doxorubicin in Metastatic and Unresectable Soft-Tissue Sarcoma

openalex（2023）

引用0浏览0引用

Supplemental Table 4 from Phase II Study of Pembrolizumab in Combination with Doxorubicin in Metastatic and Unresectable Soft-Tissue Sarcoma

Michael B. Livingston,Megan H. Jagosky,Myra Robinson,William A. Ahrens,Jennifer H. Benbow,Carol Farhangfar,David M. Foureau,Deirdre M. Maxwell,Emily A. Baldrige,Xhevahire Begic,James T. Symanowski,Nury Steuerwald, Christopher Anderson,Joshua C. Patt,Jeffrey S. Kneisl, Edward S. Kim

openalex（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn